NASD · Healthcare · Medical Devices · USA
Rapid Micro Biosystems Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.
Rapid Micro Biosystems provides automated microbial quality control solutions for pharmaceutical manufacturing. The company's Growth Direct platform automates testing workflows for detecting contamination in drug production, replacing manual laboratory processes with robotic systems and advanced imaging technology. It serves pharmaceutical manufacturers globally, including producers of biologics, vaccines, and cell and gene therapies.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Rapid Micro Biosystems Inc stock.
Fairly valued: intrinsic value $0.71 per share, market price $0.74, margin of safety -3.7% (as of 2026-11-17).
A 0.9x revenue multiple, discounted for its losses, values the shares at $0.71; the price of $0.74 is 4% above that value.
2 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
15 more in this industry show a wider margin of safety.
RPID is fairly valued (as of the 2026-11-17 close). A 0.9x revenue multiple, discounted for its losses, values the shares at $0.71; the price of $0.74 is 4% above that value.
$0.71 per share (as of the 2026-11-17 close), against a market price of $0.74. That is a margin of safety of -3.7%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.